Critical Comparison: Prothena (NASDAQ:PRTA) vs. Sonnet BioTherapeutics (NASDAQ:SONN)
Prothena (NASDAQ:PRTA – Get Free Report) and Sonnet BioTherapeutics (NASDAQ:SONN – Get Free Report) are both small-cap medical companies, but which is the superior business? We will compare the two companies based on the strength of their profitability, earnings, analyst recommendations, risk, valuation, dividends and institutional ownership. Insider & Institutional Ownership 97.1% of Prothena shares […]
More Stories
Southern Copper (NYSE:SCCO) PT Raised to $100.00
Southern Copper (NYSE:SCCO – Free Report) had its target price hoisted by Citigroup from $99.44 to $100.00 in a report...
Arteris, Inc. (NASDAQ:AIP) CEO Sells $39,633.60 in Stock
Arteris, Inc. (NASDAQ:AIP – Get Free Report) CEO K Charles Janac sold 5,520 shares of Arteris stock in a transaction...
Insider Buying: MyState Limited (ASX:MYS) Insider Purchases A$35,950.00 in Stock
MyState Limited (ASX:MYS – Get Free Report) insider Brett Morgan acquired 10,000 shares of the stock in a transaction that...
Insider Selling: Block, Inc. (NYSE:SQ) CAO Sells $33,500.00 in Stock
Block, Inc. (NYSE:SQ – Get Free Report) CAO Ajmere Dale sold 500 shares of the business’s stock in a transaction...
Humana (NYSE:HUM) Rating Lowered to Market Perform at Leerink Partners
Leerink Partners cut shares of Humana (NYSE:HUM – Free Report) from an outperform rating to a market perform rating in...
Michael Skynner Sells 972 Shares of Bicycle Therapeutics plc (NASDAQ:BCYC) Stock
Bicycle Therapeutics plc (NASDAQ:BCYC – Get Free Report) CTO Michael Skynner sold 972 shares of Bicycle Therapeutics stock in a...